Skip to content

Royalty Pharma Plc Price, Chart & Factor Analysis

Free Data & Analytics Access

Latest earnings: November 4, 2026 results vs estimates

Royalty Pharma Plc · E.RPRX.NASDAQ · United States
Use symbol E.RPRX.NASDAQ in our API & Excel add-in to retrieve this data ↓
65.93
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 26.00%

Royalty Pharma Plc Forecast

Royalty Pharma Plc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.0% a year, a typical one-standard-deviation range is 63.52–68.34 over a week, 60.98–70.88 over a month and 48.79–83.07 over a year. (Signals as of 1 Nov 2026.)

Royalty Pharma Plc Price Chart

MacroFinance.ai

Royalty Pharma Plc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Royalty Pharma Plc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Royalty Pharma Plc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Royalty Pharma Plc
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Royalty Pharma Plc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Royalty Pharma Plc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Royalty Pharma Plc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Royalty Pharma Plc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Royalty Pharma Plc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Royalty Pharma Plc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Royalty Pharma Plc (United States)

Royalty Pharma Plc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Royalty Pharma Plc?
Royalty Pharma Plc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Royalty Pharma Plc price?
The latest close is 65.93 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Royalty Pharma Plc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Royalty Pharma Plc?
20-day realised volatility is 26.0% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 7.5% over a month and 3.7% over a week.
What factors affect Royalty Pharma Plc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Royalty Pharma Plc, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Royalty Pharma Plc?
58 backtested tactical asset allocation strategies trade Royalty Pharma Plc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Royalty Pharma Plc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Royalty Pharma Plc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Royalty Pharma Plc historical data?
In the Free historical data section of this page: the last 10 years of Royalty Pharma Plc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Royalty Pharma Plc historical data (last 10 years)

Browse or instantly download the last 10 years of Royalty Pharma Plc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RPRX.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2068.45
2026-11-1967.72
2026-11-1868.67
2026-11-1768.68
2026-11-1668.525
2026-11-1369.31
2026-11-1268.735
2026-11-1169.7715
2026-11-1069.2134
2026-11-0968.5357
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.